Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Deferred Taxes: 2015-2022

Historic Deferred Taxes for ImmunityBio (IBRX) over the last 8 years, with Dec 2022 value amounting to -$4,000.

  • ImmunityBio's Deferred Taxes rose 96.14% to -$8,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.9 million, marking a year-over-year increase of 36.04%. This contributed to the annual value of -$4,000 for FY2022, which is 50.00% up from last year.
  • According to the latest figures from FY2022, ImmunityBio's Deferred Taxes is -$4,000, which was up 50.00% from -$8,000 recorded in FY2021.
  • ImmunityBio's Deferred Taxes' 5-year high stood at -$4,000 during FY2022, with a 5-year trough of -$2.9 million in FY2020.
  • For the 3-year period, ImmunityBio's Deferred Taxes averaged around -$983,333, with its median value being -$8,000 (2021).
  • In the last 5 years, ImmunityBio's Deferred Taxes crashed by 36,625.00% in 2020 and then spiked by 99.73% in 2021.
  • Over the past 5 years, ImmunityBio's Deferred Taxes (Yearly) stood at -$498,000 in 2018, then soared by 98.39% to -$8,000 in 2019, then slumped by 36,625.00% to -$2.9 million in 2020, then skyrocketed by 99.73% to -$8,000 in 2021, then skyrocketed by 50.00% to -$4,000 in 2022.